Evinacumab(anti-ANGPTL3)

Evinacumab is a monoclonal antibody that targets, binds to, and pharmacologically inhibits ANGPTL3, which can act as a complementary agent to other LDL-C lowering regimens for patients aged 12 or older with HoFH.

• Supplier: Selleck Chemicals
• Product #: A2049
• Sku #: A2049-1mg*5